Painkiller Remoxy (Oxycodone) Resubmitted To FDA
Remoxy (oxycodone), designed to provide 24-hour pain relief for moderate to severe pain, has been re-submitted to the FDA (Food and Drug Administration) by King Pharmaceuticals Inc. and Pain Therapeutics Inc. Remoxy is also designed for long-term use. The re-submission follows an FDA Complete Response Letter (CRL) sent in 2008. According to King Pharmaceuticals, "This is a Class 2 resubmission ...

Three Upcoming Make-or-Break Biotech Approvals
These highly anticipated new therapies are about to face judgment day.

If you could rename Obamacare what would you call it? (Morning Read)
Among today's current medical news: Obamacare renamed, new funds and managers in healthcare venture capital, a pair of notable FDA NON-approvals, fresh praise for the CREST study, and Modern Healthcare's looks back at 2010.